Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
10 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/11/2702265/0/en/Acerus-Update.html
26 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/01/26/2596258/0/en/Acerus-Files-For-CCAA-Protection.html
26 Dec 2022
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2022/12/26/2579502/0/en/Acerus-Announces-Resignation-of-Director.html
03 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/03/2526708/0/en/Acerus-Announces-Amendment-to-Promissory-Note-Due-to-Former-Serenity-Shareholders.html
21 Sep 2022
// Max Bayer FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/cash-depleted-acerus-undergoes-strategic-review-spark-corporate-magic
23 Aug 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/08/23/2502855/0/en/Acerus-Announces-Resignation-of-CFO-Effective-November-20-2022.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE